|
Study of ALTO-300 in MDD
RECRUITINGPhase 2Sponsored by Alto Neuroscience
Actively Recruiting
PhasePhase 2
SponsorAlto Neuroscience
Started2023-06-08
Est. completion2026-12
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
Locations45 sites
View on ClinicalTrials.gov →
NCT05922878
Summary
The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics.
Eligibility
Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria: * Have a diagnosis of moderate to severe major depressive disorder (MDD) * At Visit 1, currently taking a single SSRI, SNRI, or bupropion for at least 6 weeks with no dose modifications in the past 2 weeks by Visit 2 * Willing to comply with all study assessments and procedures * Must not be pregnant or breastfeeding at time of enrollment or throughout study Exclusion Criteria: * Evidence of unstable medical condition * Nightly use of sleep medication * Diagnosed bipolar disorder, psychotic disorder, or dementia * Current moderate or severe substance use disorder * Has a history of hypersensitivity or allergic reaction to ALTO-300 or any of its components/excipients * Concurrent or recent participation in another clinical trial for mental illness involving an investigational product or device
Conditions2
DepressionMajor Depressive Disorder
Interventions1
Locations45 sites
Find trials near these locations
Depression trials in PhoenixDepression trials in Los AngelesDepression trials in Colorado SpringsDepression trials in TampaDepression trials in ChicagoDepression trials in Las VegasDepression trials in AlbuquerqueDepression trials in Oklahoma CityDepression trials in DallasDepression trials in Fort WorthAll trials in ArizonaAll trials in CaliforniaAll trials in ColoradoAll trials in FloridaAll trials in GeorgiaAll trials in IllinoisAll trials in LouisianaAll trials in NevadaAll trials in New MexicoAll trials in New YorkAll trials in North CarolinaAll trials in OhioAll trials in OklahomaAll trials in PennsylvaniaAll trials in TexasAll trials in Virginia
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorAlto Neuroscience
Started2023-06-08
Est. completion2026-12
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
Locations45 sites
View on ClinicalTrials.gov →
NCT05922878